Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Cash Flow Quality Index
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow Quality Index of 3.52x as of September 2025. Operating cash flow of CN¥201.83 Million exceeds net income of CN¥57.27 Million, indicating high earnings quality where cash backs reported profits. Explore Jiangsu Kanion Pharmaceutical Co Ltd (600557) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Quality Index (2001–2024)
Historical Cash Flow Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Jiangsu Kanion Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year earnings quality comparison for Jiangsu Kanion Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Jiangsu Kanion Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.84x | CN¥702.49 Million | CN¥380.92 Million | ▲ +1.8% |
| 2023 | 1.81x | CN¥972.32 Million | CN¥536.73 Million | ▼ -21.0% |
| 2022 | 2.29x | CN¥995.94 Million | CN¥434.47 Million | ▼ -18.1% |
| 2021 | 2.80x | CN¥908.30 Million | CN¥324.35 Million | ▲ +9.5% |
| 2020 | 2.56x | CN¥701.10 Million | CN¥274.03 Million | ▲ +42.8% |
| 2019 | 1.79x | CN¥925.73 Million | CN¥516.51 Million | ▲ +23.2% |
| 2018 | 1.45x | CN¥636.39 Million | CN¥437.60 Million | ▲ +43.6% |
| 2017 | 1.01x | CN¥382.93 Million | CN¥378.18 Million | ▲ +27.4% |
| 2016 | 0.79x | CN¥299.02 Million | CN¥376.15 Million | ▼ -43.6% |
| 2015 | 1.41x | CN¥514.80 Million | CN¥365.24 Million | ▲ +46.2% |
| 2014 | 0.96x | CN¥311.54 Million | CN¥323.11 Million | ▼ -25.3% |
| 2013 | 1.29x | CN¥388.11 Million | CN¥300.68 Million | ▲ +46.1% |
| 2012 | 0.88x | CN¥212.11 Million | CN¥240.14 Million | ▲ +85.6% |
| 2011 | 0.48x | CN¥90.19 Million | CN¥189.46 Million | ▼ -47.6% |
| 2010 | 0.91x | CN¥166.40 Million | CN¥183.21 Million | ▲ +766.2% |
| 2009 | -0.14x | CN¥-21.87 Million | CN¥160.40 Million | ▼ -133.4% |
| 2008 | 0.41x | CN¥58.39 Million | CN¥142.99 Million | ▼ -57.0% |
| 2007 | 0.95x | CN¥92.73 Million | CN¥97.57 Million | ▼ -43.1% |
| 2006 | 1.67x | CN¥108.98 Million | CN¥65.21 Million | ▼ -17.8% |
| 2005 | 2.03x | CN¥101.44 Million | CN¥49.89 Million | ▲ +346.9% |
| 2004 | 0.45x | CN¥21.68 Million | CN¥47.66 Million | ▼ -2.2% |
| 2003 | 0.47x | CN¥17.13 Million | CN¥36.81 Million | ▼ -12.7% |
| 2002 | 0.53x | CN¥11.15 Million | CN¥20.93 Million | ▼ -53.2% |
| 2001 | 1.14x | CN¥21.02 Million | CN¥18.45 Million | — |